<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="167909">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00911599</url>
  </required_header>
  <id_info>
    <org_study_id>2006-506</org_study_id>
    <nct_id>NCT00911599</nct_id>
  </id_info>
  <brief_title>RCT Comparing Ion Levels and Clinical Outcomes of A-Class BFH to Metal on Polyethylene Total Hip Replacement</brief_title>
  <acronym>RCT</acronym>
  <official_title>A Prospective Randomized Clinical Trial Comparing Ion Levels and Clinical Outcomes of the CONSERVE速 A-Class Total Hip System With BFH速 Technology to Metal on Polyethylene Total Hip Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wright Medical Technology</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to demonstrate that blood ion levels (cobalt and chromium)
      are lower at one year in patients who receive a metal on polyethylene total hip as compared
      to CONSERVE速 A-Class Total Hip with BFH速 technology. Secondary aims include the gathering of
      clinical data regarding survival and dislocation rates at two years post surgery, as well as
      the assessment of pain, physical function, radiographic and clinical outcome at the two year
      interval.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary purpose of this study is therefore, to compare the metal ion levels between the advanced metal system and the traditional metal on polyethylene total hip replacement system.</measure>
    <time_frame>Multiple time points out to (2) two years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Hip Joint</condition>
  <condition>Osteoarthritis</condition>
  <condition>Arthroplasty</condition>
  <arm_group>
    <arm_group_label>BFH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>BFH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metal with Polyethylene Liner</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Metal with Polyethylene Liner</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>A Class BFH</intervention_name>
    <description>A Class BFH versus Metal on Poly</description>
    <arm_group_label>BFH</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Metal on Polyethylene</intervention_name>
    <description>A Class BFH versus Metal on Poly</description>
    <arm_group_label>Metal with Polyethylene Liner</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals undergoing unilateral total hip replacement.

          -  Patients 50 to 70 years of age.

        Exclusion Criteria:

          -  Patients who have previously undergone any type of joint replacement.

          -  Patients with evidence of active infection.

          -  Patients with a documented allergy to cobalt chromium molybdenum.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul E Beaule, MD, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Ottawa / The Ottawa Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ottawa Hospital - General Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K2B 6X1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 21, 2014</lastchanged_date>
  <firstreceived_date>May 29, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Individuals undergoing unilateral total hip replacement.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
